Business Segment Information (Tables)

12 Months Ended

Jul. 31, 2025

Business Segment Information [Abstract]

Schedule of Operating Results for the Business Segments

Operating results for the business segments of the Company are as follows:

(in thousands)	Healthcare			Infusion Technology			Real Estate			Total
Year Ended July 31, 2025
Infusion technology revenue	$	—		$	93		$	—		$	93
Rental – Third Party		—			—			197			197
Rental – Related Party		—			—			112			112
Product revenue		515			—			—			515
COSTS AND EXPENSES
Cost of Infusion Technology revenue		—			(106	)		—			(106	)
Cost of product revenue		(28	)		—			—			(28	)
General and administrative		(13,165	)		(320	)		(296	)		(13,781	)
Research and development		(12,568	)		(255	)		—			(12,823	)
Depreciation and amortization		(48	)		(177	)		(63	)		(288	)
Loss on impairment of goodwill		—			(3,050	)		—			(3,050	)
Loss from operations	$	(25,294	)	$	(3,815	)	$	(50	)	$	(29,159	)

(in thousands)	Healthcare			Infusion Technology			Real Estate			Total
Year Ended July 31, 2024
Infusion technology revenue	$	—		$	355		$	—		$	355
Rental – Third Party		—			—			174			174
Rental – Related Party		—			—			108			108
COSTS AND EXPENSES
Cost of Infusion Technology revenue		—			(154	)		—			(154	)
General and administrative		(8,338	)		(374	)		(142	)		(8,854	)
Research and development		(3,668	)		(502	)		—			(4,170	)
In-process research and development		(89,861	)		—			—			(89,861	)
Depreciation and amortization		(165	)		—			(60	)		(225	)
(Loss) income from operations	$	(102,032	)	$	(675	)	$	80		$	(102,627	)

A reconciliation between loss from operations by reportable segment to consolidated net loss before income taxes for the years ended July 31, 2025 and 2024, is as follows:

(in thousands)	July 31, 2025			July 31, 2024
(Loss) income from operations by segment
Healthcare	$	(25,294	)	$	(102,032	)
Infusion Technology		(3,815	)		(675	)
Real Estate		(50	)		80
Total		(29,159	)		(102,627	)
Reconciliation to loss before income taxes:
Interest income		1,996			2,383
Loss on initial investment in Day Three upon acquisition		—			(1,633	)
Realized gain on available-for-sale securities		178			1,772
Realized loss on investment in equity securities		—			(46	)
Realized gain on investment - Cyclo		—			424
Unrealized (loss) gain on investment - Cyclo		(5,144	)		37
Unrealized (loss) gain on convertible notes receivable, due from Cyclo		(719	)		1,191
Unrealized gain on investment - Hedge Funds		—			63
Recovery of receivables from Cornerstone		—			31,305
Interest expense		(658	)		(248	)
Other income, net		310			118
Loss before income taxes	$	(33,196	)	$	(67,261	)

Schedule of Net Property, Plant and Equipment

Net property, plant, and equipment and total assets summarized by geographic area are as follows:

(in thousands)	United States		Israel		Total
July 31, 2025
Property, plant and equipment, net	$	321	$	1,275	$	1,596
Total assets		111,954		2,155		114,109
July 31, 2024
Property, plant and equipment, net	$	783	$	1,337	$	2,120
Total assets		93,434		3,398		96,832